ArticleTherapeutic advances in medical oncology2024

Effectiveness and safety of first-line pembrolizumab plus chemotherapy in patients with advanced/recurrent or metastatic esophageal squamous cell carcinoma in China: a real-world multicenter study.

Yu Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.